Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients
Public ClinicalTrials.gov record NCT03927144. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-month Prospective, Randomized, Interventional, Global, Multi-center, Active-controlled Study Comparing Sustained Benefit of Two Treatment Paradigms (AMG334 qm vs. Oral Prophylactics) in Adult Episodic Migraine Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the sustained long-term benefit between two treatment paradigms of migraine prophylactic agents (erenumab versus a control arm of oral prophylactics) in episodic migraine patients who have previously failed 1 to 2 prophylactic migraine treatments.
Study identification
- NCT ID
- NCT03927144
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 621 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2019 (Actual)
- Primary completion
- Oct 1, 2021 (Actual)
- Completion
- Sep 30, 2022 (Actual)
- Last update posted
- Nov 18, 2023
2019 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Headache Center | Stanford | California | 94305 | — |
| Yale Center for Clinical Research | New Haven | Connecticut | 06519 | — |
| New England Institute for Neurology and Headache | Stamford | Connecticut | 06905 | — |
| George Washington Hospital | Washington D.C. | District of Columbia | 20037 | — |
| University of Miami Headache Division | Miami | Florida | 33136 | — |
| Premier Research Institute | West Palm Beach | Florida | 33407 | — |
| Diamond Headache Clinic | Chicago | Illinois | 60642 | — |
| Robbins Headache Clinic | Riverwoods | Illinois | 60015 | — |
| Medvadis | Watertown | Massachusetts | 02472 | — |
| New England Regional Headache Center, Inc | Worcester | Massachusetts | 01605 | — |
| MHNI | Ann Arbor | Michigan | 48104 | — |
| Clinical Research Institute | Minneapolis | Minnesota | 55402 | — |
| The Headache Center | Ridgeland | Mississippi | 38157 | — |
| Study Metrix Research | City of Saint Peters | Missouri | 63303 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Laszlo Mechtler | Amherst | New York | 14226 | — |
| Jefferson Headache Center | Philadelphia | Pennsylvania | 19107 | — |
| Nashville Neuroscience Group | Nashville | Tennessee | 37203 | — |
| Texas Neurology | Dallas | Texas | 75214 | — |
| Texas Institute for Neurological Disorders | Sherman | Texas | 75092 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03927144, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2023 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03927144 live on ClinicalTrials.gov.